Home/Filings/4/0001209191-16-094869
4//SEC Filing

Kura Oncology, Inc. 4

Accession 0001209191-16-094869

$KURACIK 0001422143operating

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:16 PM ET

Size

5.4 KB

Accession

0001209191-16-094869

Insider Transaction Report

Form 4
Period: 2016-01-29
LIU YI
Chief Scientific Officer
Transactions
  • Award

    Option to purchase common stock

    2016-01-29+50,00050,000 total
    Exercise: $4.80Exp: 2026-01-28Common stock (50,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 equal monthly installments commencing on the grant date.

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001422143

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:16 PM ET
Size
5.4 KB